跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PARMOL 250 SUSPENSION 250 mg/5 ml - HSA Drug Approval Details
Approvals
/
HSA
/
PARMOL 250 SUSPENSION 250 mg/5 ml
Approved
THERAPEUTIC
PARMOL 250 SUSPENSION 250 mg/5 ml
HOVID BHD
🇸🇬 Health Sciences Authority
Approval Date
Mar 20, 1991
Approval ID
5349d390e7ed9bba
Company
HOVID BHD
Type
Therapeutic
Approval Details
Approval Id
5349d390e7ed9bba
Drug Name
PARMOL 250 SUSPENSION 250 mg/5 ml
Product Name
PARMOL 250 SUSPENSION 250 mg/5 ml
Approval Number
SIN05565P
Approval Date
1991-03-20
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Licence Holder
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SUSPENSION
Route Of Administration
ORAL
Atc Code
N02BE01
Atc Item Name
paracetamol
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
PARACETAMOL
250 mg/5 ml
PARACETAMOL
250 mg/5 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 20, 1991
Approval ID
5349d390e7ed9bba
Type
Therapeutic
Back to HSA Approvals